Clarify the Role of Veozah for Hot Flashes

July 2023

Veozah (fezolinetant) will be a new nonhormonal med for managing moderate to severe hot flashes during menopause.

It’s the first neurokinin 3 antagonist. It blocks neurokinin B, a chemical that regulates temperature...decreasing vasomotor symptoms.

Tell patients to expect a benefit of about 2 or 3 fewer hot flashes per day with Veozah 45 mg po once daily compared to placebo.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology Know How Inpefa Stacks Up to Other SGLT2 Inhibitors
Heart Failure Consider Key Meds to Optimize HFpEF Regimens
Practice Continue to Address Nonmedical Factors Impacting Care
Menopause Clarify the Role of Veozah for Hot Flashes
Hypothyroidism Clear Up Misconceptions About Hypothyroidism
Allergic Reactions Be Specific When Recording an Allergy to Iodine
Warts Help Patients Manage Pesky Warts
Pediatrics Be Ready to Address Hypertension in Kids and Teens
Opioids Stay Alert for Opioid-Induced Hyperalgesia